Informizely customer feedback surveys
Choose HA
†
OAKneePainRelief.com
About OA*
What is OA*
Symptoms
Causes
Diagnosis
Treatment Options
Additional Resources
Choose GELSYN-3
Choose GELSYN-3
What is GELSYN-3?
How GELSYN-3 works
Is GELSYN-3 right for me?
Resources
FAQ
KneeMail
Physician Locator
Healthcare Provider
Proven HA
†
Innovation
Science-driven Results
Safety
Resources
Journal Articles
Videos
Choose GELSYN-3 with confidence for your patients
35
In a clinical trial, fewer treatment-related adverse events were reported with GELSYN-3 compared to Synvisc.
35
93% – 97% of patients and investigators scored the global tolerability as good or very good.
GELSYN-3 patients showed a 37% reduction in pain medication use.
The most common adverse event with GELSYN-3 was injection site pain (0.5%)
GELSYN-3 performed as well as Synvisc in terms of effectiveness and safety, providing patients with long-lasting, clinically relevant pain relief.
35